Power estimation in biomarker studies where events are already observed.
Background: The clinical utility of a new biomarker should ideally be established in a prospective randomized clinical trial. However, such trials are not always practical. As such, it is common for investigators to identify promising biomarkers using archived specimens and clinical data collected f...
| Publicado en: | Clinical Trials Vol. 14; no. 6; pp. 621 - 629 |
|---|---|
| Autor principal: | |
| Formato: | equations & formulas research tables/charts Journal Article |
| Publicado: |
Sage Publications, Ltd.
Dec2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |